학술논문

Evans syndrome in a patient with COVID‐19.
Document Type
Article
Source
British Journal of Haematology. Jul2020, Vol. 190 Issue 2, pe59-e61. 3p. 1 Graph.
Subject
*COVID-19
*AUTOIMMUNE hemolytic anemia
*MIDDLE East respiratory syndrome
*SYNDROMES
*SARS virus
Language
ISSN
0007-1048
Abstract
Keywords: clinical haematology; immune thrombocytopenia; anaemia EN clinical haematology immune thrombocytopenia anaemia e59 e61 3 07/20/20 20200715 NES 200715 Evans syndrome (ES) is a rare condition characterised by the combination of autoimmune haemolytic anaemia and immune thrombocytopenia (ITP). Nonetheless, treatment options are limited for patients with COVID-19 in this context, and further data are needed to guide the use of immunosuppression in patients with autoimmune complications of SARS coronavirus 2. Until more data emerge on the use of corticosteroids in setting of COVID-19, avoidance of corticosteroids should be considered in autoimmune haematological diseases in patients with COVID-19 in favour of alternative therapies. [Extracted from the article]